Overlooked brain protein tied to epilepsy yields first inhibitors in early experiments. Scientists at the Icahn School of Medicine at Mount Sinai have uncovered the first high-resolution structure of NBCn2, a brain protein linked to epilepsy, autism spectrum disorder and other neurological conditions, and developed the first compounds capable of inhibiting its activity.
A apuração publicada por medicalxpress.com vira base para uma leitura editorial direta e contextualizada.
Trechos de apoio da pauta: Scientists at the Icahn School of Medicine at Mount Sinai have uncovered the first high-resolution structure of NBCn2, a brain protein linked to epilepsy, autism spectrum disorder and other neurological conditions, and developed the first compounds capable of inhibiting its activity. The findings provide a new framework for studying how altered brain signaling contributes to disease and may help advance future therapeutic research.
- Ponto de atenção: overlooked.
- Ponto de atenção: brain.
- Ponto de atenção: protein.
Em resumo, a leitura editorial acompanha o impacto do tema no nicho Fitness.
